HCA Healthcare dividend and valuation

HCA · NYSE · USD

Compare HCA Healthcare
$501.19Change from previous close: −2.07%Absolute change: −$10.59

Close · November 17, 2026

Valuation

HCA Healthcare paid $3.06 per share in dividends over the last 12 months (yield 0.6%). Next ex-dividend date: December 15, 2026. The P/E ratio is 17.0. The average price target of 22 analysts is $483.41.

Data as of November 17, 2026

HCA Healthcare compared with similar companies

HCA Healthcare's P/E (trailing 12 months): 17.0, in line with the median of a group of 11 similar companies (17.2).

HCA Healthcare's metrics compared with similar companies
MetricHCA HealthcareMedian25th–75th percentileBand
P/E (trailing 12 months)17.017.214.9 – 29.3Middle
Forward P/E16.316.313.4 – 22.8Middle
EV/EBITDA10.211.58.18 – 16.6Middle
Price/sales1.361.361.09 – 2.78Middle
Gross margin42.8%35.5%27.4% – 43.5%Middle
Operating margin15.3%15.3%11.5% – 18.9%Middle
Net margin8.6%8.1%7.4% – 10.3%Middle

Group: the stock and up to 10 companies in the same industry (with fewer than 5, related industries too), same region first, with a similar size. Band: low = the lowest quarter of values in the group, middle = 25th to 75th percentile, high = the highest quarter. Negative multiples and multiples above 500 are excluded; a comparison needs at least 5 values. The group is recalculated nightly.

TickerLandia analysisHow it is calculated

Companies in the group: same industry, similar size

HCA Healthcare: valuation over time

On the latest fiscal year's earnings (2025), HCA Healthcare's P/E today is 17.7, above the median of its last 10 fiscal years (14.0; between 10.1 and 16.5 from 2016 to 2025). Relative to earnings, the stock costs more than it used to. The dividend yield (0.6%) is below the median of the last 8 fiscal years (0.9%).

HCA Healthcare P/E and dividend yield at each fiscal year end
Fiscal yearPrice at year endEarnings per shareP/EDividend per shareYield
2025$466.86$28.3316.5$2.880.6%
2024$300.15$22.0013.6$2.640.9%
2023$270.68$18.9714.3$2.400.9%
2022$239.96$19.1512.5$2.240.9%
2021$256.92$21.1612.1$1.920.7%
2020$164.46$10.9315.0$0.430.3%
2019$147.81$10.0714.7$1.601.1%
2018$124.45$10.6611.7$1.401.1%
2017$87.84$5.9514.8——
2016$74.02$7.3010.1——

TickerLandia calculation: closing price on the last trading day of the fiscal year divided by diluted earnings per share from the annual report (positive earnings only); yield = dividend per share for the year divided by the same price. Prices adjusted for splits. Today's P/E is today's price divided by the latest fiscal year's earnings per share, so it compares with the years above; today's yield uses dividends over the last 12 months.

TickerLandia analysisHow it is calculated

Other metrics

Valuation multiples

Market cap
$106.91B
Enterprise value
$161.79B
PEG
1.53
EV/revenue
2.06

Profitability and growth

ROA
12.2%
ROIC
21.4%
Revenue growth (year over year)
3.6%
Earnings growth (year over year)
4.5%

Financial health

Total cash
$1.02B
Total debt
$52.43B
Current ratio
0.82
Quick ratio
0.63
Altman Z-Score
2.52
Piotroski F-Score
6.00

Dividends

Annual dividend per share
$3.06
Dividend yield
0.6%
Payout ratio
10.1%
Ex-dividend date
December 15, 2026

Analysts and estimates

Average price target
$483.41
Median price target
$488.00
High price target
$585.00
Low price target
$380.00
Analysts with a price target
22
Consensus
Buy
Forward EPS
$31.30
EPS estimate, current year
$30.05

Shares and trading

Beta
1.10
Average volume
1.36M
Shares outstanding
208.89M
Float
136.72M
Institutional ownership
78.3%
Insider ownership
17.2%
Short interest (% of float)
3.6%
Short ratio (days)
3.82